Health Care
/
Post Views: 0

Takeda AS
PHARMACEUTICALS

Export Market

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia

Additional Information

  • Finance
    Operating income: 2.472.980
    Operating profit: 936.804
    Operating profit before tax: 933.679
    Total assets: 3.705.023
    Total equity: 2.946.451
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Ingeborg Rossebø Borgheim

    Board Members:
    Athinagoras Efthymios Giannoulis
    Bjørn Lie
    Finn Thomlevold Tennøe
    Knut Meinich Aastebøl
    Marchand Duarte Lourinho
    Mona Jensen Breivik

    General Manager:
    Bjørn Lie


    Subsidiary companies:
    Largest shareholders:
    N/A
  • Trademarks
    Calcigran,

Trademarks

Calcigran,

KEYWORDS

    blood-forming organs and the cardiovascular system, Medicinal products, Medicinal products for the blood, Pharmaceutical & Medical Chemical Products, Pharmaceutical & Medical Consumables, Pharmaceutical & Medicinal Chemicals, Pharmaceutical articles, Vitamins & nutrients,

Related Companies

Featured

Norwegian Special Mission signs contract with Textron Aviation

Featured

Global Trade AS Eastern Norway

Global Trade is a international seafood trading specialist. Quality and freshness is their concern no.1. Buy fish directly...

Featured

Norsk Hydro Asa

Contact
info@norwayexports.no
08.00 - 16.00
Your gateway to the Norwegian export market
Search Norway's largest database of exporters:
• 35 business sectors
• 2000 product groups
• 8000 products & services
• Companies, trademarks, products or services
SINCE 1957
javo-footer-info-image
© 2020 | By Medievekst AS
X